Shares of Johnson & Johnson /zigman2/quotes/201724570/composite JNJ -0.10% inched 0.29% higher to $170.67 Wednesday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index /zigman2/quotes/210599714/realtime SPX +2.59% rising 2.13% to 4,210.24 and the Dow Jones Industrial Average /zigman2/quotes/210598065/realtime DJIA +2.66% rising 1.63% to 33,309.51. The stock's rise snapped a four-day losing streak. Johnson & Johnson closed $16.02 below its 52-week high ($186.69), which the company achieved on April 25th.
The stock demonstrated a mixed performance when compared to some of its competitors Wednesday, as Roche Holding AG Part. Cert. /zigman2/quotes/206948568/delayed RHHVF -0.62% rose 0.58% to $334.06, Merck & Co. Inc. /zigman2/quotes/209956077/composite MRK +1.66% fell 0.37% to $89.19, and Pfizer Inc. /zigman2/quotes/202877789/composite PFE +0.87% rose 0.34% to $49.95. Trading volume (5.6 M) remained 1.1 million below its 50-day average volume of 6.7 M.